Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-11 5:57 pm Purchase | 2025-04-04 | 13G | AURA BIOSCIENCES INC AURA | Montanova Capital, LLC | 3,057,319 6.100% | 3,057,319 (New Position) | Filing History |
| 2025-04-11 4:46 pm Purchase | 2025-04-07 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Montanova Capital, LLC | 15,176,015 9.900% | 15,176,015 (New Position) | Filing History |
| 2025-03-28 4:50 pm Purchase | 2025-03-26 | 13D | BENITEC BIOPHARMA INC BNTC | Montanova Capital, LLC | 15,623,659 49.900% | 1,293,722 (+9.03%) | Filing History |
| 2025-03-11 7:22 pm Purchase | 2025-03-04 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | Montanova Capital, LLC | 4,727,510 9.990% | 4,727,510 (New Position) | Filing History |
| 2025-02-13 8:15 pm Sale | 2024-12-31 | 13G | KURA ONCOLOGY INC KURA | Montanova Capital, LLC | 5,198,189 6.700% | -2,274,154 (-30.43%) | Filing History |
| 2025-02-13 8:09 pm Sale | 2024-12-31 | 13G | ERASCA INC ERAS | Montanova Capital, LLC | 12,315,004 4.400% | -1,453,035 (-10.55%) | Filing History |
| 2025-02-13 8:00 pm Purchase | 2024-12-31 | 13G | 89BIO INC ETNB | Montanova Capital, LLC | 10,202,696 8.500% | 2,211,052 (+27.67%) | Filing History |
| 2025-02-11 8:51 pm Purchase | 2025-02-04 | 13G | IMMATICS N V IMTX | Montanova Capital, LLC | 7,881,608 6.500% | 7,881,608 (New Position) | Filing History |
| 2025-02-11 8:45 pm Purchase | 2025-02-07 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Montanova Capital, LLC | 3,022,612 5.500% | 917,348 (+43.57%) | Filing History |
| 2025-02-11 8:20 pm Sale | 2024-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Montanova Capital, LLC | 2,105,264 3.800% | -3,358,377 (-61.47%) | Filing History |
| 2025-02-07 5:36 pm Purchase | 2025-02-05 | 13G | PEPGEN INC PEPG | Montanova Capital, LLC | 1,660,932 5.100% | 486,611 (+41.44%) | Filing History |
| 2025-02-07 5:16 pm Sale | 2024-12-31 | 13G | PEPGEN INC PEPG | Montanova Capital, LLC | 1,174,321 3.600% | -486,611 (-29.30%) | Filing History |
| 2025-01-06 4:50 pm Purchase | 2024-12-27 | 13G | FULCRUM THERAPEUTICS INC FULC | Montanova Capital, LLC | 3,404,612 6.300% | 2,221,821 (+187.85%) | Filing History |
| 2024-12-20 4:56 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | Montanova Capital, LLC | 714,463 8.600% | 714,463 (New Position) | Filing History |
| 2024-12-04 4:32 pm Purchase | 2024-11-26 | 13G | ARRIVENT BIOPHARMA INC AVBP | Montanova Capital, LLC | 2,040,365 6.100% | 2,040,365 (New Position) | Filing History |
| 2024-11-18 4:36 pm Purchase | 2024-11-14 | 13D | BENITEC BIOPHARMA INC BNTC | Montanova Capital, LLC | 14,329,937 49.900% | 5,500,884 (+62.30%) | Filing History |
| 2024-11-14 4:28 pm Purchase | 2024-09-30 | 13G | ZURA BIO LTD ZURA | Montanova Capital, LLC | 4,860,939 7.600% | 2,010,939 (+70.56%) | Filing History |
| 2024-11-14 4:25 pm Sale | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Montanova Capital, LLC | 1,182,791 2.200% | -4,336,090 (-78.57%) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Montanova Capital, LLC | 0 0.000% | -36,854,190 (Position Closed) | Filing History |
| 2024-11-14 3:57 pm Purchase | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Montanova Capital, LLC | 4,328,904 9.990% | 1,644,899 (+61.29%) | Filing History |